Antibiotic prophylaxis: The role of selective bowel decontamination

Current Opinion in Organ Transplantation

Volumn 6, Issue 4, 2001, Pages 301-304

  Arnow, Paul M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBOXYMETHYLCELLULOSE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; NORFLOXACIN; NYSTATIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG TOLERABILITY; ERADICATION THERAPY; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; INFECTION RATE; LIVER FAILURE; LIVER TRANSPLANTATION; MYCOSIS; OPERATION DURATION; OUTCOMES RESEARCH; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SUSPENSION;

EID: 0035683823     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200112000-00005     Document Type: Review

References (22)

1. Bacterial infections complicating liver transplantation: Epidemiology and risk factors
2. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients
3. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients
4. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation
5. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation
6. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations
7. Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients
8. Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation
9. Pathogenesis of early operative site infections after orthotopic liver transplantation
10. Selective decontamination of the digestive tract helps prevent early bacterial infections in the early postoperative period after liver transplant
11. A prospective, randomized, double-blinded evaluation of selective bowel decontamination in liver transplantation
12. Selective decontamination in pediatric liver transplants: A randomized prospective study
13. Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination
14. Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients
15. Major bacterial infections following liver transplantation: A prospective study
16. Selective bowel decontamination in hospitalized patients awaiting liver transplantation
17. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis
18. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin
19. The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination
20. The efficacy of selective bowel decontamination as infection prevention after liver transplantation
21. Early severe infections after orthotopic liver transplantation
22. One-thousand liver transplants: The lessons learned